# VDYNE, INC.: Form D filings

VDYNE, INC., a biotechnology company in Maple Grove, MN, filed 4 Form D notices with the SEC between 2018 and 2020. The latest, on December 18, 2020, reports $8 million sold of a $8 million offering to 2 investors.

Find out what VDYNE, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20VDYNE%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=VDYNE%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fvdyne-inc-1758658)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20VDYNE%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=VDYNE%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fvdyne-inc-1758658)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 10900 73RD AVENUE NORTH, SUITE 116, Maple Grove, MN, 55369
- Phone: (763) 777-5969
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1758658

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 18, 2020 | New notice | $8,000,001 | $8,000,001 | $0 | 2 | Dec 9, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1758658/000175865820000006/0001758658-20-000006-index.htm) |
| Aug 31, 2020 | New notice | $13,000,062 | $13,000,062 | $0 | 42 | Aug 14, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1758658/000157689620000004/0001576896-20-000004-index.htm) |
| Jan 2, 2020 | New notice | $6,800,000 | $6,799,999 | $1 | 36 | Dec 18, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1758658/000175865820000003/0001758658-20-000003-index.htm) |
| Dec 11, 2018 | New notice | $5,204,175 | $5,204,175 | $0 | 36 | Aug 1, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1758658/000175865818000001/0001758658-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Greg Pearl | Director |  |
| Robert Vidlund | Executive Officer, Director |  |
| Jean-Raymond Boulle II | Director |  |
| Lucian Lozonschi | Director |  |
| David McIntyre | Executive Officer, Director |  |

## Other biotechnology companies in Minnesota that filed recently

- [Medical 21, Inc.](https://specstream.ai/data/form-d/company/medical-21-inc-1673688) $550,000 · Oct 23, 2026
- [InSitu Biologics, Inc.](https://specstream.ai/data/form-d/company/insitu-biologics-inc-1723443) $1.3 million · Oct 14, 2026
- [Evia Bio, Inc.](https://specstream.ai/data/form-d/company/evia-bio-inc-1954759) $5.5 million · Sep 28, 2026
- [EyeMacular Regeneration, Inc.](https://specstream.ai/data/form-d/company/eyemacular-regeneration-inc-2042485) $2.9 million · Sep 25, 2026
- [ProEncia Biotechnology Inc.](https://specstream.ai/data/form-d/company/proencia-biotechnology-inc-2103044) $1.5 million · Aug 26, 2026

[Every Form D from the week of Dec 14, 2020](https://specstream.ai/data/form-d/week/2020-12-14) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what VDYNE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).